Hospital Hygiene Monitoring — June 2026

In brief — Andes hantavirus cases in France, WHO-declared Public Health Emergency of International Concern (PHEIC) for Bundibugyo Ebola, updated Standard Precautions from SF2H, the French national infection-control congress in Lille, and a landmark report from the French Court of Auditors on healthcare-associated infections: May–June 2026 brings dense news for Infection Prevention and Control (IPC) teams and Infection Control Committees.

Period covered: 12 May to 9 June 2026 — Scope: France, Europe, international.
Main sources: SF2H, CPias (Lille, Occitanie, Centre-Val de Loire), HAS, Santé publique France, ECDC, WHO, CDC, Eurosurveillance, French Court of Auditors, FDA, national agencies (PHAC, UKHSA, THL).

📄 Full report (PDF)

The full 12-page report (in French, with an acronyms glossary in appendix) is available for download below:

Hospital Hygiene Monitoring — June 2026 (PDF, French)Download

1. Epidemiological and health alerts

Andes hantavirus — MV Hondius cluster (EU/EEA)

A cluster of severe respiratory syndrome aboard a Dutch expedition vessel: 9+ confirmed cases, including at least 2 hospitalised in France (1 in ICU in Paris on 11 May) and 1 in Spain. Person-to-person transmission is limited but possible in confined settings. Impact: high (hospitalised cases on French soil).

IPC action: standard + droplet/airborne precautions, isolation in a well-ventilated single room, full PPE (FFP2/respirator, eye protection, gown, gloves), airborne precautions for any aerosol-generating procedure, infectious-waste handling, contact tracing for 42 days following WHO precautionary principle.

Sources: CPias CHU Lille · WHO DON 13/05/2026 · European Commission

Bundibugyo Ebola — DRC + Uganda (PHEIC 17/05/2026)

More than 513 cases and 130 suspected deaths (BDBV strain — no approved vaccine or treatment). EU/EEA importation risk assessed as very low, but requires robust hospital readiness. Impact: high if imported.

IPC action: update “Identify, Isolate, Inform” SOPs, verify availability and mastery of high-risk PPE (PAPR, double gloving), revise the suspect-patient pathway (negative-pressure room, dedicated team, biohazard waste management), update screening criteria (travel < 21 days to affected area + fever/symptoms).

Sources: WHO 17/05/2026 · ECDC Threat Assessment 21/05/2026 · NETEC 18/05/2026

CPO outbreak — Royal Victoria Hospital, Belfast (13/05/2026)

Outbreak of carbapenemase-producing Enterobacterales (CPE) in a medical/urgent-care unit. Measures: extended screening, enhanced environmental cleaning, cohorting. Impact: moderate (external signal). IPC action: monitor; strengthen admission screening for patients hospitalised in the UK in the last 12 months. NI Digest

NDM-CRE — rising trend in the USA (CDC, 07/06/2026)

CDC/ASM study: the majority of NDM-CRE cases are driven by a small number of dominant strains (≈ 50% K. pneumoniae, ≈ 31% E. coli). Highlights the value of genomic surveillance for early cluster detection. Impact: moderate. ASM source

2. Key scientific publications

Eurosurveillance (June 2026) — Andes hantavirus: under current evidence, community outbreak size at 4 months < 50 cases with high probability of extinction if > 50% of cases are isolated early. Reassuring for in-hospital management contingent on early isolation. Eurosurveillance Vol 31 (22)
Post-extubation pneumonia vs VAP: post-extubation pneumonia, a distinct mechanism (dysphagia, impaired airway protection), now outnumbers ventilator-associated pneumonia. Implication: extend prevention bundles beyond mechanical ventilation. Conexiant Pulmonary
WGS for HAI cluster detection: any new pathogen detection > 1 month after admission is a highly specific marker for HAI and cluster transmission. Strong argument for integrating sequencing into MDRO surveillance. PubMed 41879325
CCDR Canada report (May 2026) — 2020-2024 surveillance: 109 hospitals (CNISP). C. difficile and MRSA-BSI stable; significant rise in VRE-BSI (0.30 → 0.42 /10,000 pd, p=0.01) and CPE (0.05 → 0.20 /10,000 pd, p=0.03); C. auris increasing. CCDR 52-5
Hand hygiene compliance: “moderate” compliance confirmed in a multicentric observational study. Supports repeated hand-hygiene audits. The Bioscan

3. Official recommendations and documents

SF2H — Updated Standard Precautions (May 2026): new SP leaflet, key message: “the first barrier, for every care act, in every setting, for every patient, by every professional”. To be deployed in wards and integrated into onboarding training. SF2H
36th SF2H Congress — Lille, 3-5 June 2026: HAI, MDRO/CPE/CPO and environmental hygiene experience reports. Programme
French Court of Auditors — Quality and safety of care report (April 2026): ≈ 4,000 direct deaths/year linked to HAI (> road mortality in France), €2.2-5.2 bn/year cost, massive under-reporting of serious adverse events (7,200 declared in 2024 vs 160,000-375,000 estimated), QualiScope rated “incomplete and little known”. 11 recommendations including financial sanctions for non-compliant facilities from 2027. An opportunity for IPC teams to position HAI traceability as a HAS certification priority. Sécurité Patient
CPias Occitanie — Newsletter #1 (May 2026): 2026 programme, CPE days (23 June, Centre-Val de Loire), HAI in disability/medico-social facilities, hemodialysis, nursing homes. CPias Occitanie
ECDC — Record bacterial STIs in 2024 + Doxy-PEP guidance: gonorrhea +303% since 2015, syphilis x2. Indirect impact on hospital antibiotic prescribing and AMR surveillance. ECDC 21/05/2026
FDA — Olympus endoscope recalls (March 2026): Class II OER-Pro recall (MAJ-1443/1444 valves), TJF duodenoscope recall. Audit valve compatibility and use-to-reprocessing delay. FDA summary
Joint Commission (USA) — National Performance Goal #5 (2026): requirement for continuous, objective measurement of hand-hygiene compliance. A signal for French IPC teams considering automated monitoring. GuardRFID

4. Weak signals to watch

Dominant NDM-CRE strains identified by WGS in the USA: possible emergence of a clone with strong diffusion potential.
Post-extubation pneumonia: a distinct, under-recognised entity — monitor adoption of dedicated bundles.
S. aureus BSI rising in Finland (THL: +44% incidence 2015 → 2024). To be compared with French SPARES data.
Media pressure following the Court of Auditors report: prepare open IPC communication for user committees.
Early heatwave in May 2026 (orange alerts in 17 départements): risk of hospital overload + impact on SP / hand-rub compliance under staffing strain.

5. IPC operational summary

Immediate (this week)

Issue an internal “Andes hantavirus” note with identification criteria and isolation procedure (well-ventilated single room, full PPE, 42-day contact tracing).
Replace ward Standard Precautions posters with the updated SF2H 2026 version.
Verify availability and training on Ebola/HCID PPE (high-risk kit, double gloving, PAPR if available) — update “Identify, Isolate, Inform” SOP.

For discussion in IPC committee (1-2 weeks)

Position on post-extubation pneumonia: extend the VAP bundle with systematic dysphagia screening, oral care and posture.
HAI improvement plan ahead of HAS certification in response to the Court of Auditors report: outcome indicators, serious-event traceability, user communication.
Audit endoscope reprocessing pathway (Olympus valves, use-to-reprocessing delay) following FDA recalls.

To monitor

Evolution of the Bundibugyo Ebola PHEIC (weekly ECDC updates).
VRE and CPE trends in France via upcoming SPARES/CPias data.
Operational details of the 2027 financial sanction for serious-event under-reporting.
Post-Lille SF2H Congress publications for inclusion in the next monthly review.

An acronyms glossary (French agencies, international agencies, hospital structures, infections and microbiology, care practices, surveillance) is included in the downloadable PDF above.

Dr Jean-Etienne Podik — Public health physician, specialist in hospital hygiene and healthcare-associated infection epidemiology.